PriceSpective, a value strategy consultancy that provides pricing and reimbursement services to pharmaceutical and biotechnology companies, has hired two senior experts for its UK office. Walter Colasante, join office as vice president, and Sophie Murdoch, as director.
Colasante, with 20 years of experience in healthcare, will contribute to PriceSpective’s pricing and reimbursement knowledge and client guidance, and will enhance PriceSpective’s forecasting and portfolio and risk management services.
Murdoch comes with 12 years of pharmaceutical experience. Murdoch will play a key role in developing strategic guidance for clients that synchronizes pricing and commercial goals.
Steve Slovick, CEO of PriceSpective, said: “With ever-increasing pressure on drug pricing and debates over healthcare reforms across the globe. We are delighted to bring on two, senior-level experts whose unique and diverse experiences will ensure the continuation of high quality services to our clients in a dynamic marketplace.”
Keiron Sparrowhawk, UK based partner, said: “Walter and Sophie will be invaluable in the continued growth and expansion of PriceSpective, enabling us to further meet our clients’ needs.”